Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Third Quarter Trading Statement

27 Oct 2011 07:00

RNS Number : 9104Q
Croda International PLC
27 October 2011
 



27 October 2011

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2011, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report good turnover and profit progress in the third quarter, driven by sales growth and margin improvement in our core businesses.

 

For the three months ended 30 September 2011, Group sales from continuing operations increased 5.1% to £265.6m (2010: £252.6m). In most business areas we saw an improving trend during the quarter.

 

Operating profit from continuing operations increased 18.3% to £57.6m (2009: £48.7m). Interest costs fell, resulting in continuing pre-tax profit increasing 20.8% to £57.4m (2010: £47.5m).

Year-to-date, the pre-tax profit from continuing operations is up 27.1% at £182.2m (2010: £143.4m).

 

Consumer Care continued to trade strongly in the third quarter, reporting a significant increase in sales (+13.6%) and operating profit (+30.8%) and improved margins versus the corresponding quarter in 2010. Sales and operating profits in all business areas within Consumer Care were well ahead of 2010.

 

Industrial Specialities turnover declined 3.5% against the tough comparatives of a particularly strong third quarter in 2010. The shortfall was in July, with sales in the rest of the period ahead of 2010. Operating profit was down 6.8% with a decrease in commodity and by-product profitability being partially mitigated by stronger performances elsewhere in the sector.

 

Net debt reduced by £15.5m to £237.8m in the quarter (2010: £240.7m) despite completing the £50m buyback programme in the period.

 

Croda continues to trade well and we expect to report further progress in the final quarter and into 2012."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

FTI Consulting

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 562 815 and quote "Croda International" to gain access to the call.

 

Additional Information

 

 

 

 

 

£m

Q3

9 months

2011

2010

2011

2010

Consumer Care

145.6

128.2

+13.6%

439.2

392.6

+11.9%

Industrial Specialities

120.0

124.4

-3.5%

386.0

371.9

+3.8%

Continuing turnover

265.6

252.6

+5.1%

825.2

764.5

+7.9%

Consumer Care

42.5

32.5

+30.8%

130.5

103.6

+26.0%

Industrial Specialities

15.1

16.2

-6.8%

52.4

45.6

+14.9%

Continuing operating profit

57.6

48.7

+18.3%

182.9

149.2

+22.6%

Operating margin

 

21.6%

 

19.3%

 

 

 

22.2%

 

19.5%

 

 

 

Interest

(0.2)

(1.2)

(0.7)

(5.8)

Continuing pre tax profit

57.4

47.5

+20.8%

182.2

143.4

+27.1%

 

 

 

 

Analysis of Q3 turnover uplift

Price/mix

+18.4%

Volume

-14.8%

Currency translation

+1.5%

Continuing turnover increase

+5.1%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMFBATMBJTBIB
Date   Source Headline
31st Oct 20165:31 pmRNSHolding(s) in Company
31st Oct 20163:17 pmRNSDirector/PDMR Shareholding
18th Oct 20169:15 amRNSHolding(s) in Company
12th Oct 20167:01 amRNSDirector Declaration
11th Oct 20165:44 pmRNSDirector/PDMR Shareholding
7th Oct 20164:06 pmRNSHolding(s) in Company
6th Oct 20165:32 pmRNSHolding(s) in Company
5th Oct 20165:54 pmRNSDirector/PDMR Shareholding
5th Oct 20163:47 pmRNSHolding(s) in Company
16th Sep 201611:50 amRNSDirector/PDMR Shareholding
13th Sep 20165:30 pmRNSHolding(s) in Company
13th Sep 20164:49 pmRNSDirector/PDMR Shareholding
12th Sep 20165:07 pmRNSHolding(s) in Company
11th Aug 20163:01 pmRNSDirector/PDMR Shareholding
5th Aug 20164:51 pmRNSHolding(s) in Company
5th Aug 20163:28 pmRNSDirector/PDMR Shareholding
4th Aug 20169:40 amRNSHolding(s) in Company
2nd Aug 20165:17 pmRNSHolding(s) in Company
2nd Aug 20165:13 pmRNSHolding(s) in Company
27th Jul 20165:28 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSResults for the six months ended 30 June 2016
13th Jul 20163:22 pmRNSDirector/PDMR Shareholding
12th Jul 20165:35 pmRNSHolding(s) in Company
11th Jul 20162:23 pmRNSHolding(s) in Company
8th Jul 201610:50 amRNSHolding(s) in Company
13th Jun 20168:00 amRNSDirector/PDMR Shareholding
7th Jun 201612:25 pmRNSDirector/PDMR Shareholding
31st May 20169:54 amRNSHolding(s) in Company
11th May 20163:49 pmRNSDirector/PDMR Shareholding
3rd May 20165:16 pmRNSHolding(s) in Company
29th Apr 201612:22 pmRNSDirector/PDMR Shareholding
28th Apr 20164:00 pmRNSTransaction in Own Shares
28th Apr 201612:09 pmRNSHolding(s) in Company
28th Apr 201612:06 pmRNSResult of AGM
27th Apr 20167:00 amRNSTrading update for the first quarter of 2016
25th Apr 201610:57 amRNSDirector/PDMR Shareholding
12th Apr 20162:46 pmRNSDirector/PDMR Shareholding
4th Apr 20165:41 pmRNSHolding(s) in Company
31st Mar 20164:52 pmRNSHolding(s) in Company
21st Mar 20165:45 pmRNSAnnual Financial Report
21st Mar 20163:20 pmRNSDirector/PDMR Shareholding
21st Mar 20163:19 pmRNSHolding(s) in Company
17th Mar 20167:00 amRNSCapital Markets Event
14th Mar 201612:07 pmRNSHolding(s) in Company
11th Mar 20164:12 pmRNSDirector/PDMR Shareholding
10th Mar 20169:59 amRNSDirector/PDMR Shareholding
7th Mar 20162:51 pmRNSDirector/PDMR Shareholding
3rd Mar 20164:52 pmRNSHolding(s) in Company
29th Feb 20165:03 pmRNSHolding(s) in Company
23rd Feb 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.